Skip to main content
. 2020 Dec 10;14(12):e0008917. doi: 10.1371/journal.pntd.0008917

Table 6. Clinical data and follow up in the leprosy patients treated.

Supervised monthly MDT-dose 1st 2nd 3rd 4th 5 th 6 th 7 th 8 th 9 th 10th 11th 12th
Number of followed-up patients 29 25 21 13 12 11 9 6 4 2 2 2
Signs & Symptoms
Improvement of neurological symptoms (cramps, numbness and/or tingling) P14 P26
P13
P28
P25
P06
P20
P25
Improvement of neural pain on palpation P14 P13 P28
Improvement of esthesiometry P26 P25 P18
Improvement of WHO impairment grading P25 P06
P20
Appearing of ichthyosis in islets in the lower limbs P26
P13
P06
P26
P20
P32 P32 P25
Improvement of skin sensitivity P27
Conjunctival eye irritability/dryness P32 P06 P32
Skin lesions became more evident P09
Skin lesions became less evident P31 P31 P11
Appearing of numbness and cramps P27
Improvement of cutaneous reflex by endogenous histamine test P31
Neuritis P11
Pain on neural palpation P18
Total patients with manifest symptoms/signs 0 1 6 2 2 0 5 3 1 1 1

P: patient.